Related Experiment Video

Updated: Jul 12, 2026

Engineering Tendon Assembloids to Probe Cellular Crosstalk in Disease and Repair
08:32

Engineering Tendon Assembloids to Probe Cellular Crosstalk in Disease and Repair

Published on: March 22, 2024

Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue disease

Lewis J Rubin1, Carol M Black, Christopher P Denton

  • 1Division of Pulmonary and Critical Care Medicine, University of California San Diego, Campus Point Drive, La Jolla, California 92037-7381, USA. ljrubin@ucsd.edu

Arthritis Research & Therapy
|September 15, 2007
PubMed

Insights

Systemic sclerosis is complex with limited treatments. Further research requires multidisciplinary collaboration for large-scale trials targeting disease modulators.

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Systemic sclerosis pathogenesis is incompletely understood despite advances.
  • Current treatment options for systemic sclerosis are limited.
  • Disease complexity necessitates novel therapeutic strategies.

Purpose of the Study:

  • To highlight the need for multidisciplinary collaboration in systemic sclerosis research.
  • To emphasize characterizing clinical and prognostic parameters.
  • To advocate for large-scale clinical trials targeting disease modulators.

Main Methods:

  • Literature review and expert consensus synthesis.
  • Analysis of current research gaps in systemic sclerosis.
  • Framework development for future clinical trial design.

Main Results:

  • Identification of key areas for improved understanding of systemic sclerosis.
  • Outlined strategies for better patient stratification in clinical trials.
  • Emphasis on targeting specific disease modulators.

Conclusions:

  • Multidisciplinary collaboration is crucial for advancing systemic sclerosis research.
  • Standardized characterization of clinical and prognostic parameters is essential.
  • Well-defined populations and targeted therapies are key for future trials.

Related Concept Videos

Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Introduction to Connective Tissues01:11

Introduction to Connective Tissues

Connective tissues are one of the four main tissue types in humans that are extensively present in the body. They are characterized by cells embedded in an extracellular matrix (ECM) composed of a ground substance and three main types of protein fibers— collagen, elastic, and reticular fibers. The ground substance of connective tissues can range from a watery and jelly-like consistency to mineralized and hard. The wide variety of cells in the connective tissues include fibroblasts, osteocytes,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...